COVID-19 and Cardiac Enzymes
Since December 2019, the COVID-19 pandemic has caused widespread mortality and adverse economic impact throughout the world. Though predominantly a respiratory disease, concerns regarding cardiovascular effects have been highlighted. Cardiac biomarkers and their elevations in COVID-19 have been asso...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/79960 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: COVID-19 and Cardiac Enzymes
- Unraveling the Significance of Phage-Derived Enzymes for Treating Secondary Bacterial Infections among COVID-19 Patients
- Enzymes in Poultry Feed
- Enzyme-Replacement Therapy in Fabry Disease
- Deiodinase Enzymes and Their Activities in Graves’ Hyperthyroidism
- Pharmacogenetics of Cancer and DNA Repair Enzymes
- Alternative Perspectives of Enzyme Kinetic Modeling